Brands
YSTV
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
Yourstory
search

Brands

Resources

Stories

General

In-Depth

Announcement

Reports

News

Funding

Startup Sectors

Women in tech

Sportstech

Agritech

E-Commerce

Education

Lifestyle

Entertainment

Art & Culture

Travel & Leisure

Curtain Raiser

Wine and Food

Videos

ADVERTISEMENT

India needs regulatory body for medical devices: Kiran Mazumdar-Shaw

India needs regulatory body for medical devices: Kiran Mazumdar-Shaw

Wednesday March 01, 2017 , 2 min Read

Biotech entrepreneur Kiran Mazumdar-Shaw has called for establishing a standard-setting regulatory body for medical devices, as non-certified ones put patients at serious risk. The Chairperson and Managing Director of biotechnlogy firm Biocon told PTI,

"I certainly think we need to have a standard setting regulatory body for medical devices. Precision of any medical intervention is critical as we cannot afford to have non-certified medical devices in the market as we will put patients at serious risk."
Image: Kiran Mazumdar-Shaw

On the National Pharmaceutical Pricing Authority's recent decision fixing price caps on coronary stents, Mazumdar-Shaw said price control on stents need to factor in the design and material of their construction.

"Stents are not generic. NPPA needs to understand," she said.

"NPPA is an important pharma pricing regulator. However, they need to negotiate prices upfront and not in an adhoc manner after launch," Mazumdar-Shaw commented when asked about its functioning and scope for improvement.


Read More :

Kiran Mazumdar Shaw becomes the recipient of the highest French honor

Need to promote medtech startups in a big way to attract investment: Kiran Mazumdar-Shaw


According to her, a credible regulatory and quality compliance system that benchmarks to internationally acceptable standards is needed to promote medical devices sector, including exports.

Earlier this month, NPPA cut prices of life-saving coronary stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 for drug eluting variety.

The maximum retail prices of bare metal stents and drug eluting stents would be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.

A coronary stent is a tube-shaped device placed in the arteries that supply blood to the heart. It keeps the arteries open in the treatment of coronary heart diseases.


Read More :

Lessons on success from 15 powerful women leaders

Lift regulations on startups, help them flourish: Kiran Mazumdar-Shaw